460 related articles for article (PubMed ID: 19393243)
1. Structural basis for bivalent Smac-mimetics recognition in the IAP protein family.
Cossu F; Milani M; Mastrangelo E; Vachette P; Servida F; Lecis D; Canevari G; Delia D; Drago C; Rizzo V; Manzoni L; Seneci P; Scolastico C; Bolognesi M
J Mol Biol; 2009 Sep; 392(3):630-44. PubMed ID: 19393243
[TBL] [Abstract][Full Text] [Related]
2. Design and characterization of bivalent Smac-based peptides as antagonists of XIAP and development and validation of a fluorescence polarization assay for XIAP containing both BIR2 and BIR3 domains.
Nikolovska-Coleska Z; Meagher JL; Jiang S; Kawamoto SA; Gao W; Yi H; Qin D; Roller PP; Stuckey JA; Wang S
Anal Biochem; 2008 Mar; 374(1):87-98. PubMed ID: 18023397
[TBL] [Abstract][Full Text] [Related]
3. Targeting the X-linked inhibitor of apoptosis protein through 4-substituted azabicyclo[5.3.0]alkane smac mimetics. Structure, activity, and recognition principles.
Mastrangelo E; Cossu F; Milani M; Sorrentino G; Lecis D; Delia D; Manzoni L; Drago C; Seneci P; Scolastico C; Rizzo V; Bolognesi M
J Mol Biol; 2008 Dec; 384(3):673-89. PubMed ID: 18851976
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs.
Zobel K; Wang L; Varfolomeev E; Franklin MC; Elliott LO; Wallweber HJ; Okawa DC; Flygare JA; Vucic D; Fairbrother WJ; Deshayes K
ACS Chem Biol; 2006 Sep; 1(8):525-33. PubMed ID: 17168540
[TBL] [Abstract][Full Text] [Related]
5. Structural insight into inhibitor of apoptosis proteins recognition by a potent divalent smac-mimetic.
Cossu F; Milani M; Vachette P; Malvezzi F; Grassi S; Lecis D; Delia D; Drago C; Seneci P; Bolognesi M; Mastrangelo E
PLoS One; 2012; 7(11):e49527. PubMed ID: 23166698
[TBL] [Abstract][Full Text] [Related]
6. Theoretical studies on the interactions of XIAP-BIR3 domain with bicyclic and tricyclic core monovalent Smac mimetics.
Ling B; Dong L; Zhang R; Wang Z; Liu Y; Liu C
J Mol Graph Model; 2010 Nov; 29(3):354-62. PubMed ID: 20980180
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain.
Liu Z; Sun C; Olejniczak ET; Meadows RP; Betz SF; Oost T; Herrmann J; Wu JC; Fesik SW
Nature; 2000 Dec 21-28; 408(6815):1004-8. PubMed ID: 11140637
[TBL] [Abstract][Full Text] [Related]
8. Biochemical basis for enhanced binding of peptide dimers to X-linked inhibitor of apoptosis protein.
Splan KE; Allen JE; McLendon GL
Biochemistry; 2007 Oct; 46(42):11938-44. PubMed ID: 17910418
[TBL] [Abstract][Full Text] [Related]
9. The structure of the BIR3 domain of cIAP1 in complex with the N-terminal peptides of SMAC and caspase-9.
Kulathila R; Vash B; Sage D; Cornell-Kennon S; Wright K; Koehn J; Stams T; Clark K; Price A
Acta Crystallogr D Biol Crystallogr; 2009 Jan; 65(Pt 1):58-66. PubMed ID: 19153467
[TBL] [Abstract][Full Text] [Related]
10. A mechanistic insight into SMAC peptide interference with XIAP-Bir2 inhibition of executioner caspases.
Abhari BA; Davoodi J
J Mol Biol; 2008 Sep; 381(3):645-54. PubMed ID: 18619610
[TBL] [Abstract][Full Text] [Related]
11. Protein-protein recognition as a first step towards the inhibition of XIAP and Survivin anti-apoptotic proteins.
Obiol-Pardo C; Granadino-Roldán JM; Rubio-Martinez J
J Mol Recognit; 2008; 21(3):190-204. PubMed ID: 18438971
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a heterodimeric Smac-based peptide that features sequences specific to both the BIR2 and BIR3 domains of the X-linked inhibitor of apoptosis protein.
Speer KF; Cosimini CL; Splan KE
Biopolymers; 2012; 98(2):122-30. PubMed ID: 22020922
[TBL] [Abstract][Full Text] [Related]
13. A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis.
Srinivasula SM; Hegde R; Saleh A; Datta P; Shiozaki E; Chai J; Lee RA; Robbins PD; Fernandes-Alnemri T; Shi Y; Alnemri ES
Nature; 2001 Mar; 410(6824):112-6. PubMed ID: 11242052
[TBL] [Abstract][Full Text] [Related]
14. Solid phase synthesis of Smac/DIABLO-derived peptides using a 'Safety-Catch' resin: identification of potent XIAP BIR3 antagonists.
Elsawy MA; Martin L; Tikhonova IG; Walker B
Bioorg Med Chem; 2013 Sep; 21(17):5004-11. PubMed ID: 23886811
[TBL] [Abstract][Full Text] [Related]
15. Interaction of a cyclic, bivalent smac mimetic with the x-linked inhibitor of apoptosis protein.
Nikolovska-Coleska Z; Meagher JL; Jiang S; Yang CY; Qiu S; Roller PP; Stuckey JA; Wang S
Biochemistry; 2008 Sep; 47(37):9811-24. PubMed ID: 18717598
[TBL] [Abstract][Full Text] [Related]
16. Designing Smac-mimetics as antagonists of XIAP, cIAP1, and cIAP2.
Cossu F; Mastrangelo E; Milani M; Sorrentino G; Lecis D; Delia D; Manzoni L; Seneci P; Scolastico C; Bolognesi M
Biochem Biophys Res Commun; 2009 Jan; 378(2):162-7. PubMed ID: 18992220
[TBL] [Abstract][Full Text] [Related]
17. A NMR and computational study of Smac mimics targeting both the BIR2 and BIR3 domains in XIAP protein.
Potenza D; Belvisi L; Vasile F; Moroni E; Cossu F; Seneci P
Org Biomol Chem; 2012 Apr; 10(16):3278-87. PubMed ID: 22407164
[TBL] [Abstract][Full Text] [Related]
18. Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database.
Nikolovska-Coleska Z; Xu L; Hu Z; Tomita Y; Li P; Roller PP; Wang R; Fang X; Guo R; Zhang M; Lippman ME; Yang D; Wang S
J Med Chem; 2004 May; 47(10):2430-40. PubMed ID: 15115387
[TBL] [Abstract][Full Text] [Related]
19. Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer.
Oost TK; Sun C; Armstrong RC; Al-Assaad AS; Betz SF; Deckwerth TL; Ding H; Elmore SW; Meadows RP; Olejniczak ET; Oleksijew A; Oltersdorf T; Rosenberg SH; Shoemaker AR; Tomaselli KJ; Zou H; Fesik SW
J Med Chem; 2004 Aug; 47(18):4417-26. PubMed ID: 15317454
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Potent SMAC Mimetics that Sensitize Cancer Cells to TNF Family-Induced Apoptosis.
Welsh K; Milutinovic S; Ardecky RJ; Gonzalez-Lopez M; Ganji SR; Teriete P; Finlay D; Riedl S; Matsuzawa S; Pinilla C; Houghten R; Vuori K; Reed JC; Cosford ND
PLoS One; 2016; 11(9):e0161952. PubMed ID: 27617834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
